Inhibition of mycobacterial CYP125 enzyme by sesamin and β-sitosterol: An in silico and in vitro study
Background: Cholesterol degradation pathway is one of the important pathways in survival of Mycobacterium tuberculosis (Mtb) bacilli, and steroid C26-monooxygenase (CYP125) enzyme of Mtb associated with this pathway is reported to be novel drug target. This study aims to find out novel, safe, and ef...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Biomedical and Biotechnology Research Journal |
Subjects: | |
Online Access: | http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2017;volume=1;issue=1;spage=49;epage=54;aulast=Wankhade |